Pharmabiz

CSOs and patient groups welcomes IPO's rejection of patent for multi-drug resistant regimen BPaL

CSOs and patient groups welcomes IPO's rejection of patent for multi-drug resistant regimen BPaL: Our Bureau, New Delhi Wednesday, October 28, 2026, 14:10 Hrs [IST] Patient groups ...
Pharmabiz

Pandorum & Nucelion ink manufacturing pact to advance two designer-exosome programmes in ophthalmology with PRIP

Pandorum & Nucelion ink manufacturing pact to advance two designer-exosome programmes in ophthalmology with PRIP: Our Bureau, Bengaluru Wednesday, October 28, 2026, 13:45 Hrs [IST ...
Pharmabiz

TN IDMA elects new office-bearers; J Jayaseelan elevated to IDMA South Zone vice-president

TN IDMA elects new office-bearers; J Jayaseelan elevated to IDMA South Zone vice-president: Peethaambaran Kunnathoor, Chennai Wednesday, October 28, 2026, 08:00 Hrs [IST] In a maj ...
Pharmabiz

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA: Our Bureau, New Delhi Wednesday, ...
Pharmabiz

New UK MHRA research?puts needle-free Strep A vaccine?within reach

New UK MHRA research?puts needle-free Strep A vaccine?within reach: United Kingdom Wednesday, October 28, 2026, 14:00 Hrs [IST] New research by the Medicines and Healthcare produc ...
Pharmabiz

US FDA granted expanded approval to Pfizer’s Talzenna plus Xtandi for an earlier metastatic prostate cancer treatment setting

US FDA granted expanded approval to Pfizer’s Talzenna plus Xtandi for an earlier metastatic prostate cancer treatment setting: New York Wednesday, October 28, 2026, 13:00 Hrs [I ...
Pharmabiz

Alembic Pharma receives US FDA final approval for valganciclovir for oral solution

Alembic Pharma receives US FDA final approval for valganciclovir for oral solution: Our Bureau, Mumbai Wednesday, October 28, 2026, 12:20 Hrs [IST] Alembic Pharmaceuticals Limited ...
Pharmabiz

Piramal Pharma Q2 revenue rises 28 per cent

Our Bureau, Mumbai Wednesday, October 28, 2026, 12:15 Hrs [IST] Piramal Pharma Limited, a leading global pharmaceutical, health and we ...
Pharmabiz

Roche receives CE Mark for cobas smart e immunoanalyser

Roche announced that it has received the CE Mark for its cobas smart e immunoanalyser, a compact, standalone platform engineered to deliver reliable testing with a planned menu of over 100 ...
Pharmabiz

Pfizer announces positive results from phase 3 MagnetisMM-32 study of Elrexfio as monotherapy in adults with relapsed or refractory multiple myeloma

Pfizer announces positive results from phase 3 MagnetisMM-32 study of Elrexfio as monotherapy in adults with relapsed or refractory multiple myeloma: New York Wednesday, October 2 ...
Pharmabiz

AstraZeneca & Daiichi Sankyo’s Enhertu gets EU approval for adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive early breast ...

AstraZeneca & Daiichi Sankyo’s Enhertu gets EU approval for adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive early breast canc ...
Pharmabiz

KPRDO asks Micro Labs to immediately halt direct supply practices and discriminatory trade schemes

KPRDO asks Micro Labs to immediately halt direct supply practices and discriminatory trade schemes: Nandita Vijayasimha, Bengaluru Wednesday, October 28, 2026, 08:00 Hrs [IST] The ...